HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A probing dose of phenylacetate does not affect glucose production and gluconeogenesis in humans.

Abstract
Phenylacetate ingestion has been used to probe Krebs cycle metabolism and to augment waste nitrogen excretion in urea cycle disorders. Phenylalkanoic acids, including phenylacetate, have been proposed as potential therapeutic agents in the treatment of diabetes. They inhibit gluconeogenesis in the liver in vitro and reduce the blood glucose concentration in diabetic rats. The effect of sodium phenylacetate ingestion on blood glucose and the contribution of gluconeogenesis to glucose production have now been studied in 7 type 2 diabetic patients. The study was not designed to test whether the changes in glucose metabolism observed in the rat could be reproduced in humans. After an overnight fast, over a period of 1 hour, 4.8 g phenylacetate was ingested, which is the highest dose used to probe Krebs cycle metabolism. Glucose production was measured by tracer kinetics using [6,6-(2)H2]glucose and gluconeogenesis by the labeling of the hydrogens of blood glucose on (2)H20 ingestion. The concentration of phenylacetate in plasma peaked by 2 hours after its ingestion, and about 40% of the dose was excreted in 5 hours. The plasma glucose concentration and production, and the contribution of gluconeogenesis to glucose production, were unaffected by phenylacetate ingestion at the highest dose used to probe Krebs cycle metabolism.
AuthorsA Wajngot, V Chandramouli, W C Schumann, H Brunengraber, S Efendic, B R Landau
JournalMetabolism: clinical and experimental (Metabolism) Vol. 49 Issue 9 Pg. 1211-4 (Sep 2000) ISSN: 0026-0495 [Print] United States
PMID11016906 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • C-Peptide
  • Insulin
  • Phenylacetates
  • Glucagon
  • Deuterium
  • phenylacetic acid
  • Glucose
Topics
  • Aged
  • C-Peptide (blood)
  • Citric Acid Cycle
  • Deuterium
  • Female
  • Glucagon (blood)
  • Gluconeogenesis (drug effects)
  • Glucose (biosynthesis)
  • Humans
  • Insulin (blood)
  • Kinetics
  • Male
  • Middle Aged
  • Phenylacetates (administration & dosage, adverse effects, pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: